pharma news today obesity drugs glp-1 september 2025 Anti-Obesity Drug Market Size and YoY Growth Rate, 2026-2033 Study predicts 16 new obesity
Description
Byetta was discontinued in South Africa as of February 2024
Planning ahead for postpartum
Never adjust your dose on your own - dose changes should only happen under provider guidance
3 4 ) Current FDA guidelines recommend waiting until this latter person becomes sick or obese (or both) to treat them with a GLP-1 medication
doi: 10.1038/s41574-019-0176-8
